Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 29 of 376 for:    LENALIDOMIDE AND Dexamethasone

Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02158702
Recruitment Status : Active, not recruiting
First Posted : June 9, 2014
Last Update Posted : May 17, 2018
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
Haematology-Oncology, National University Hospital, Singapore

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 2018
Estimated Study Completion Date : November 2018